Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Absence of convincing evidence of Coxiella burnetii infection in Chile: a cross-sectional serosurvey among healthy adults in four different regions

Authors: Thomas Weitzel, Javier López, Gerardo Acosta-Jamett, Sophie Edouard, Philippe Parola, Katia Abarca

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Coxiella burnetii is an important zoonotic pathogen of global distribution. Still, in most parts of South America including Chile, systematic epidemiological data are lacking. The presented study aims to determine the seroprevalence of Coxiella burnetii antibodies in healthy adults of four different regions in Chile.

Methods

A cross-sectional study was performed, which included healthy adults living in rural and urban areas of four cities located in different regions in northern, central, and southern Chile. In urban sectors, households were chosen by double stratified random sampling, while in rural areas convenience sampling was performed. Serum specimens were taken and screened for the presence of IgG antibodies against C. burnetii phase II antigen using a commercial ELISA kit. Positive and indeterminate results were confirmed by a reference laboratory using indirect immunofluorescence assay (IFA).

Results

A total of 1112 individuals were included. Of those, 8 were positive by ELISA, but only one sample was confirmed using IFA. Statistical analysis for population freedom from disease revealed a high probability that C. burnetii was absent in our study population.

Conclusion

Our work provides the first epidemiological data on human Q fever in Chile indicating either a very low endemicity or the absence of this pathogen in the studied areas.
Appendix
Available only for authorised users
Literature
2.
go back to reference Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ, et al. Diagnosis and management of Q fever-United States, 2013: recommendations from CDC and the Q fever working group. MMWR Recomm Rep. 2013;62:1–30.PubMed Anderson A, Bijlmer H, Fournier PE, Graves S, Hartzell J, Kersh GJ, et al. Diagnosis and management of Q fever-United States, 2013: recommendations from CDC and the Q fever working group. MMWR Recomm Rep. 2013;62:1–30.PubMed
3.
go back to reference Million M, Raoult D. Recent advances in the study of Q fever epidemiology, diagnosis and management. J Infect. 2015;71 Suppl 1:S2–9.CrossRefPubMed Million M, Raoult D. Recent advances in the study of Q fever epidemiology, diagnosis and management. J Infect. 2015;71 Suppl 1:S2–9.CrossRefPubMed
7.
go back to reference Sanz JC, Delos Ríos R, Martín F, Tébar MA, Jadoc I, Anda P. Application of four ELISA techniques (two for IgM and two for IgG) for serological diagnosis of an outbreak of Q fever. Enferm Infecc Microbiol Clin. 2006;24:178–81.CrossRefPubMed Sanz JC, Delos Ríos R, Martín F, Tébar MA, Jadoc I, Anda P. Application of four ELISA techniques (two for IgM and two for IgG) for serological diagnosis of an outbreak of Q fever. Enferm Infecc Microbiol Clin. 2006;24:178–81.CrossRefPubMed
9.
go back to reference Raoult D. Chronic Q, fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102–8.CrossRefPubMed Raoult D. Chronic Q, fever: expert opinion versus literature analysis and consensus. J Infect. 2012;65:102–8.CrossRefPubMed
10.
go back to reference Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol. 1994;1:189–96.PubMedPubMedCentral Dupont HT, Thirion X, Raoult D. Q fever serology: cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol. 1994;1:189–96.PubMedPubMedCentral
11.
go back to reference Cameron AR, Baldock FC. A new probability formula for surveys to substantiate freedom from disease. Prev Vet Med. 1998;34:1–17.CrossRefPubMed Cameron AR, Baldock FC. A new probability formula for surveys to substantiate freedom from disease. Prev Vet Med. 1998;34:1–17.CrossRefPubMed
13.
go back to reference Anderson AD, Kruszon-Moran D, Loftis AD, Mcquillan G, Nicholson WL, Priestley RA, et al. Seroprevalence of Q fever in the United States, 2003–2004. Am J Trop Med Hyg. 2009;81:691–4.CrossRefPubMed Anderson AD, Kruszon-Moran D, Loftis AD, Mcquillan G, Nicholson WL, Priestley RA, et al. Seroprevalence of Q fever in the United States, 2003–2004. Am J Trop Med Hyg. 2009;81:691–4.CrossRefPubMed
14.
go back to reference Nielsen SY, Molbak K, Nybo Andersen AM, Brink Henriksen T, Kantso B, Krogfelt KA, Hjollund NH. Prevalence of Coxiella burnetii in women exposed to livestock animals, Denmark, 1996 to 2002. Euro Surveill. 2013;18:20528.CrossRefPubMed Nielsen SY, Molbak K, Nybo Andersen AM, Brink Henriksen T, Kantso B, Krogfelt KA, Hjollund NH. Prevalence of Coxiella burnetii in women exposed to livestock animals, Denmark, 1996 to 2002. Euro Surveill. 2013;18:20528.CrossRefPubMed
15.
go back to reference Villumsen S, Jørgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA. Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009;65:93–8.CrossRefPubMed Villumsen S, Jørgensen CS, Smith B, Uldum S, Schiellerup P, Krogfelt KA. Determination of new cutoff values for indirect immunofluorescence antibody test for Q fever diagnosis in Denmark. Diagn Microbiol Infect Dis. 2009;65:93–8.CrossRefPubMed
16.
go back to reference Blaauw GJ, Notermans DW, Schimmer B, Meekelenkamp J, Reimerink JH, Teunis P, et al. The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population. Epidemiol Infect. 2012;140:36–41.CrossRefPubMed Blaauw GJ, Notermans DW, Schimmer B, Meekelenkamp J, Reimerink JH, Teunis P, et al. The application of an enzyme-linked immunosorbent assay or an immunofluorescent assay test leads to different estimates of seroprevalence of Coxiella burnetii in the population. Epidemiol Infect. 2012;140:36–41.CrossRefPubMed
17.
go back to reference Anstey NM, Tissot Dupont H, Hahn CG, Mwaikambo ED, McDonald MI, Raoult D, et al. Seroepidemiology of Rickettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. Am J Trop Med Hyg. 1997;57:187–9.PubMed Anstey NM, Tissot Dupont H, Hahn CG, Mwaikambo ED, McDonald MI, Raoult D, et al. Seroepidemiology of Rickettsia typhi, spotted fever group rickettsiae, and Coxiella burnetti infection in pregnant women from urban Tanzania. Am J Trop Med Hyg. 1997;57:187–9.PubMed
18.
go back to reference Kampschreur LM, Hagenaars JC, Wielders CC, Elsman P, Lestrade PJ, Koning OH, et al. Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect. 2013;141:847–51.CrossRefPubMed Kampschreur LM, Hagenaars JC, Wielders CC, Elsman P, Lestrade PJ, Koning OH, et al. Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect. 2013;141:847–51.CrossRefPubMed
19.
go back to reference Schimmer B, Schotten N, van Engelen E, Hautvast JL, Schneeberger PM, van Duijnhoven YT. Coxiella burnetii seroprevalence and risk for humans on dairy cattle farms, the Netherlands, 2010–2011. Emerg Infect Dis. 2014;20:417–25.CrossRefPubMedPubMedCentral Schimmer B, Schotten N, van Engelen E, Hautvast JL, Schneeberger PM, van Duijnhoven YT. Coxiella burnetii seroprevalence and risk for humans on dairy cattle farms, the Netherlands, 2010–2011. Emerg Infect Dis. 2014;20:417–25.CrossRefPubMedPubMedCentral
20.
go back to reference Vanderburg S, Rubach MP, Halliday JE, Cleaveland S, Reddy EA, Crump JA. Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review. PLoS Negl Trop Dis. 2014;8:e2787.CrossRefPubMedPubMedCentral Vanderburg S, Rubach MP, Halliday JE, Cleaveland S, Reddy EA, Crump JA. Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review. PLoS Negl Trop Dis. 2014;8:e2787.CrossRefPubMedPubMedCentral
21.
22.
go back to reference Georgiev M, Afonso A, Neubauer H, Needham H, Thiery R, Rodolakis A, et al. Q fever in humans and farm animals in four European countries, 1982 to 2010. Euro Surveill. 2013;18:20407.PubMed Georgiev M, Afonso A, Neubauer H, Needham H, Thiery R, Rodolakis A, et al. Q fever in humans and farm animals in four European countries, 1982 to 2010. Euro Surveill. 2013;18:20407.PubMed
24.
go back to reference Edouard S, Million M, Royer G, Giorgi R, Grisoli D, Raoult D. Reduction in incidence of Q fever endocarditis: 27 years of experience of a national reference center. J Infect. 2014;68:141–8.CrossRefPubMed Edouard S, Million M, Royer G, Giorgi R, Grisoli D, Raoult D. Reduction in incidence of Q fever endocarditis: 27 years of experience of a national reference center. J Infect. 2014;68:141–8.CrossRefPubMed
25.
go back to reference Porter SR, Czaplicki G, Mainil J, Guattéo R, Saegerman C. Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol. 2011;248418. Porter SR, Czaplicki G, Mainil J, Guattéo R, Saegerman C. Q Fever: current state of knowledge and perspectives of research of a neglected zoonosis. Int J Microbiol. 2011;248418.
26.
go back to reference Guatteo R, Seegers H, Taurel AF, Joly A, Bordeau F. Prevalence of Coxiella burnetii infection in domestic ruminants: a critical review. Vet Microbiol. 2011;149:1–16.CrossRefPubMed Guatteo R, Seegers H, Taurel AF, Joly A, Bordeau F. Prevalence of Coxiella burnetii infection in domestic ruminants: a critical review. Vet Microbiol. 2011;149:1–16.CrossRefPubMed
27.
go back to reference Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D. Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg. 2014;90:915–9.CrossRefPubMedPubMedCentral Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D. Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg. 2014;90:915–9.CrossRefPubMedPubMedCentral
28.
go back to reference Davoust B, Marié JL, Pommier De Santi V, Berenger JM, Edouard S, Raoult D. Three-toed sloth as putative reservoir of Coxiella burnetii, Cayenne, French Guiana. Emerg Infect Dis. 2014;20:1760–1.CrossRefPubMedPubMedCentral Davoust B, Marié JL, Pommier De Santi V, Berenger JM, Edouard S, Raoult D. Three-toed sloth as putative reservoir of Coxiella burnetii, Cayenne, French Guiana. Emerg Infect Dis. 2014;20:1760–1.CrossRefPubMedPubMedCentral
31.
go back to reference Comité de Infecciones Emergentes de la Sociedad Chilena de Infectología. Conclusiones del primer Taller de la Red Nacional de Enfermedades Emergentes, Valparaíso 2001. El Vigía, Boletín de Vigilancia en Salud Pública de Chile. 2004;8:6–12. Comité de Infecciones Emergentes de la Sociedad Chilena de Infectología. Conclusiones del primer Taller de la Red Nacional de Enfermedades Emergentes, Valparaíso 2001. El Vigía, Boletín de Vigilancia en Salud Pública de Chile. 2004;8:6–12.
35.
go back to reference Ferrés MG, Abarca VK, Prado DV, Montecinos PL, Navarrete CM, Vial CPA. Prevalence of Bartonella henselae antibodies in Chilean children, adolescents and veterinary workers. Rev Med Chil. 2006;134:863–7.CrossRef Ferrés MG, Abarca VK, Prado DV, Montecinos PL, Navarrete CM, Vial CPA. Prevalence of Bartonella henselae antibodies in Chilean children, adolescents and veterinary workers. Rev Med Chil. 2006;134:863–7.CrossRef
Metadata
Title
Absence of convincing evidence of Coxiella burnetii infection in Chile: a cross-sectional serosurvey among healthy adults in four different regions
Authors
Thomas Weitzel
Javier López
Gerardo Acosta-Jamett
Sophie Edouard
Philippe Parola
Katia Abarca
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1880-9

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.